Key statistics
On Friday, Shanghai Junshi Biosciences Co Ltd (1877:HKG) closed at 25.20, -12.50% below its 52-week high of 28.80, set on Jun 12, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.75 |
---|---|
High | 25.95 |
Low | 24.70 |
Bid | 25.15 |
Offer | 25.20 |
Previous close | 25.10 |
Average volume | 9.54m |
---|---|
Shares outstanding | 1.03bn |
Free float | 150.34m |
P/E (TTM) | -- |
Market cap | 39.77bn HKD |
EPS (TTM) | -1.42 HKD |
Data delayed at least 15 minutes, as of Jul 18 2025 09:08 BST.
More ▼
- Junshi Biosciences Announces Ongericimab’s sNDA Approval in China
- Junshi Biosciences Announces the sNDA Approval of Toripalimab for the 1st-line Treatment of Melanoma
- Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates
- Junshi Biosciences Announces Toripalimab’s Approval in Singapore
- Junshi Biosciences Announces Approval of sNDA for Toripalimab in Combination with Bevacizumab for 1st-line Treatment of Advanced Hepatocellular Carcinoma
- Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe
- Junshi Biosciences Announces Toripalimab’s Approval in Australia
- Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab
- Junshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China’s Hong Kong SAR
- Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
More ▼